Association of single-nucleotide polymorphism (SNP) in the 5-alpha-reductase gene (SRD5A2) with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer (TC) survivors.
H. Boer
No relevant relationships to disclose
C. Meijer
No relevant relationships to disclose
J. D. Dijck-Brouwer
No relevant relationships to disclose
I. P. Kema
No relevant relationships to disclose
J. D. Lefrandt
No relevant relationships to disclose
N. Zwart
No relevant relationships to disclose
H. M. Boezen
No relevant relationships to disclose
A. J. Smit
No relevant relationships to disclose
J. A. Gietema
Research Funding - Pfizer; Roche